133 related articles for article (PubMed ID: 6106782)
1. Are elevated pancreatic polypeptide levels in patients with insulinoma secondary to hypoglycaemia?
Nelson RL; Service FJ; Ilstrup DM; Go VL
Lancet; 1980 Sep; 2(8196):659-61. PubMed ID: 6106782
[TBL] [Abstract][Full Text] [Related]
2. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies.
Friesen SR; Kimmel JR; Tomita T
Am J Surg; 1980 Jan; 139(1):61-72. PubMed ID: 6243207
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.
Mutch MG; Frisella MM; DeBenedetti MK; Doherty GM; Norton JA; Wells SA; Lairmore TC
Surgery; 1997 Dec; 122(6):1012-9; discussion 1019-20. PubMed ID: 9426414
[TBL] [Abstract][Full Text] [Related]
6. Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?
Koch MB; Go VL; DiMagno EP
Mayo Clin Proc; 1985 Apr; 60(4):259-65. PubMed ID: 2984484
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
Nelson RL; Service FJ; Go VL
Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic polypeptide update: its roles in detection of the trait for multiple endocrine adenopathy syndrome, type I and pancreatic polypeptide-secreting tumors.
Friesen SR; Tomita T; Kimmel JR
Surgery; 1983 Dec; 94(6):1028-37. PubMed ID: 6139885
[TBL] [Abstract][Full Text] [Related]
9. Documented hypoglycemia for 23 years in a patient with insulinoma.
Nelson RL; Rizza RA; Service FJ
JAMA; 1978 Oct; 240(17):1891. PubMed ID: 211277
[No Abstract] [Full Text] [Related]
10. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
[TBL] [Abstract][Full Text] [Related]
11. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
12. Effects of diet-induced ketosis in rats with hypoglycaemia due to a serially transplantable insulinoma.
Flatt PR; Swanston-Flatt SK; Snell K; Tan KS; Marks V
Diabete Metab; 1987; 13(5):503-7. PubMed ID: 2828127
[TBL] [Abstract][Full Text] [Related]
13. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas.
Pontiroli AE; Secchi A; Dabandi M; Alberetto M; Bosi E; Fantaguzzi S; Pozza G
J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737
[TBL] [Abstract][Full Text] [Related]
14. Fasting hypoglycaemia due to insulinoma in pregnancy.
Akanji AO; George AO; Olasode BJ; Osotimehin BO
Postgrad Med J; 1990 Feb; 66(772):156. PubMed ID: 2161526
[No Abstract] [Full Text] [Related]
15. Metastatic insulinoma with long survival and glucagonoma syndrome.
D'Arcangues CM; Awoke S; Lawrence GD
Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
[TBL] [Abstract][Full Text] [Related]
16. Glucose-induced GIP levels in patients with insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin response to various secretagogues in insulinoma.
Ohneda A; Kobayashi T; Nihei J
Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
[TBL] [Abstract][Full Text] [Related]
18. Plasma glucagon in insulinoma.
Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
[TBL] [Abstract][Full Text] [Related]
19. Nightly amended IRI/BG ratio in fasting test during sleeping periods in subjects with insulinoma and in normal, diabetic and obese subjects.
Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
Acta Diabetol Lat; 1984; 21(4):325-32. PubMed ID: 6099025
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus.
Nagpal SJS; Bamlet WR; Kudva YC; Chari ST
Pancreas; 2018 Jul; 47(6):738-741. PubMed ID: 29771765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]